Candace S. Johnson

发表

Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression.

J. Schellens, P. Hershberger, T. Mcguire, 2002, Molecular cancer therapeutics.

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

D. Trump, Candace S. Johnson, K. Deeb, 2007, Nature Reviews Cancer.

Structural variation discovery in the cancer genome using next generation sequencing: Computational solutions and perspectives

Song Liu, Lei Wei, Maochun Qin, 2015, Oncotarget.

Biochemical characterization of nuclear receptors for vitamin D3 and glucocorticoids in prostate stroma cell microenvironment.

S. Oñate, D. Trump, Candace S. Johnson, 2011, Biochemical and biophysical research communications.

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection

Qiang Hu, Li Yan, Matthias W. Beckmann, 2014, Oncotarget.

CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines

Donald L. Trump, Josephia R. Muindi, D. Trump, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges

Song Liu, Maochun Qin, Donald L. Trump, 2013, Oncotarget.

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, C. Morrison, 2014, Oncotarget.

Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.

S. Srivastava, Yan Zeng, Shivendra V. Singh, 2003, Carcinogenesis.

Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2

Shivendra V. Singh, D. Trump, Candace S. Johnson, 2004, Oncogene.

In Vivo Antitumor Activity and Induction of Insulin-Like Growth Factor-1-Resistant Apoptosis by SC-ααδ9

P. Wipf, J. Lazo, Candace S. Johnson, 2000 .

Interleukin‐6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway

D. Trump, Candace S. Johnson, A. Gao, 2004, The Prostate.

1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p

D. Trump, Candace S. Johnson, Rachel N. Pratt, 2017, Oncotarget.

Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25‐dihydroxycholecalciferol

B. Su, M. Seshadri, Wei-dong Yu, 2013, Cancer.

The Anti-tumor Effects of Vitamin D in Other Cancers

D. Trump, Candace S. Johnson, 2011 .

Biomarkers , Genomics , Proteomics , and Gene Regulation Generation of a Novel Transgenic Mouse Model for Bioluminescent Monitoring of Survivin Gene Activity in Vivo at Various Pathophysiological Processes Survivin Expression Overlaps with Stem Cell Markers

B. Foster, Fengzhi Li, C. Porter, 2010 .

A Novel Approach for the Identification of Unique Tumor Vasculature Binding Peptides Using an E. coli Peptide Display Library

Candace S. Johnson, M. Wong, C. Brown, 2000, Annals of Surgical Oncology.

Sulforaphane-induced Cell Death in Human Prostate Cancer Cells Is Initiated by Reactive Oxygen Species*

Simon C Watkins, S. Srivastava, Yan Zeng, 2005, Journal of Biological Chemistry.

Central quadrant procurement of radical prostatectomy specimens

C. Morrison, J. Mohler, R. Cheney, 2009, The Prostate.

18 Vitamin D and Acute Myeloid Leukemia

D. Trump, Candace S. Johnson, M. Wetzler, 2018 .

Vitamin D and Acute Myeloid Leukemia

D. Trump, Candace S. Johnson, M. Wetzler, 2011 .

Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer

M. Fakih, D. Trump, Candace S. Johnson, 2009, International Journal of Colorectal Disease.

Epigenetic silencing of CYP24 in the tumor microenvironment

D. Trump, Candace S. Johnson, I. Chung, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study

S. Yao, C. Ambrosone, S. McCann, 2012, Breast Cancer Research.

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors

M. Fakih, D. Trump, Candace S. Johnson, 2009, Cancer Chemotherapy and Pharmacology.

The Prostate

L. Arab, G. Sonpavde, E. Fontham, 2019 .

A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors

A. Hutson, M. Fakih, J. Black, 2007, Clinical Cancer Research.

Vitamin D in combination cancer treatment

D. Trump, Candace S. Johnson, Yingyu Ma, 2010, Journal of Cancer.

Vitamin D deficiency and insufficiency among patients with prostate cancer

M. Fakih, M. Nesline, D. Trump, 2009, BJU international.

Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients

R. Branch, D. Trump, Candace S. Johnson, 2006, Cancer Chemotherapy and Pharmacology.

Serum Vitamin D Metabolites in Colorectal Cancer Patients Receiving Cholecalciferol Supplementation: Correlation with Polymorphisms in the Vitamin D Genes

Zengrui Wu, A. Adjei, M. Fakih, 2013, Hormones and Cancer.

Synergistic enhancement by interleukin-1 α of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice

J. Grandis, P. Furmanski, Wei-dong Yu, 2004, Cancer Chemotherapy and Pharmacology.

Interleukin 1α and γ-interferon induction of nitric oxide production from murine tumor-derived endothelial cells

Candace S. Johnson, R. Modzelewski, M. Chang, 1996 .

IL-1α Enhancement of Platinum-Mediated Anti-Tumor Activity

P. Furmanski, Wei-dong Yu, M. Egorin, 1996 .

Antitumor Activity of Interleukin-1α and Cisplatin in a Murine Model System

J. Grandis, Wei-dong Yu, Candace S. Johnson, 1995 .

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts

C. Morrison, Q. Hu, Song Liu, 2016, Oncotarget.

Role of Caspase 2 in Apoptotic Signaling in Primate and Murine Germ Cells1

Candace S. Johnson, Zhaoyuan Hu, Yi-Xun Liu, 2008, Biology of reproduction.

The Sulfotransferase SULT1C2 Is Epigenetically Activated and Transcriptionally Induced by Tobacco Exposure and Is Associated with Patient Outcome in Lung Adenocarcinoma

M. Campan, Candace S. Johnson, S. Selamat, 2021, International journal of environmental research and public health.

Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy

Q. Hu, K. Guru, S. Glenn, 2019, The Journal of urology.

Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.

Shivendra V. Singh, D. Trump, Candace S. Johnson, 2004, Molecular cancer therapeutics.

Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers

M. Caligiuri, R. Fisher, P. Hwu, 2021, The oncologist.

Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.

Wei-dong Yu, D. Trump, Candace S. Johnson, 2006, Cancer research.

25-Dihydroxycholecalciferol ( 1 , 25-D 3 ) Inhibits the Growth of Squamous Cell Carcinoma and Down-Modulates p 21 Waf 1 / Cip 1 in Vitro and in Vivo 1

P. Hershberger, D. Trump, Candace S. Johnson, 2000 .

in Vivo and in Vitro Waf 1 / Cip 1 Squamous Cell Carcinoma and Down-Modulates p 21 ) Inhibits the Growth of 31 , 25-Dihydroxycholecalciferol ( 1 , 25-D Updated

P. Hershberger, D. Trump, Candace S. Johnson, 2000 .

A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors

M. Egorin, D. Trump, Candace S. Johnson, 2011, Investigational New Drugs.

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation

D. Trump, Candace S. Johnson, Yibing Peng, 2005, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of high‐dose oral calcitriol: Results from a phase 1 trial of calcitriol and paclitaxel

P. Hershberger, M. Egorin, D. Trump, 2002, Clinical pharmacology and therapeutics.

Anitcancer Activity of Vitamin D Analogs

D. Trump, Candace S. Johnson, M. Uskoković, 1999 .

Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.

D. Trump, Candace S. Johnson, R. Modzelewski, 2002, Endocrinology.

Gene Therapy and Endothelial Cell Targeting for Cancer

J. Lazo, Candace S. Johnson, B. Pitt, 1994, Annals of the New York Academy of Sciences.

Calcitriol enhances gemcitabine antitumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system

Wei-dong Yu, D. Trump, Candace S. Johnson, 2010, Cell cycle.

Anti-tumor activity of calcitriol: pre-clinical and clinical studies

P. Hershberger, Wei-dong Yu, D. Trump, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer

C. Ryan, D. Trump, Candace S. Johnson, 2007, Cancer Chemotherapy and Pharmacology.

Glucocorticoid regulation of the vitamin D receptor

D. Trump, Candace S. Johnson, A. Hidalgo, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Combined Effects of Circulating Levels of 25-Hydroxyvitamin D and Th1 and Th2 Cytokines on Breast Cancer Estrogen Receptor Status

S. Yao, C. Ambrosone, S. McCann, 2014, Cancers.

Phase II trial of high‐dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen‐independent prostate cancer

D. Trump, Candace S. Johnson, A. Brufsky, 2006, Cancer.

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review.

M. Fakih, D. Trump, Candace S. Johnson, 2002, Urology.

Inecalcitol, an analog of 1,25D₃, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system

Wei-dong Yu, D. Trump, Candace S. Johnson, 2013, Cell cycle.

Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer

M. Seshadri, P. Hershberger, Candace S. Johnson, 2015, Cancer Prevention Research.

MAC: identifying and correcting annotation for multi-nucleotide variations

C. Morrison, Q. Hu, Jianmin Wang, 2015, BMC Genomics.

Antitumor Effects of Recombinant Humant Interleukin 1α in RIF-1 and Panc02 Solid Tumors

V. Ord, P. Furmanski, Candace S. Johnson, 1988 .

Potentiation of Interleukin lor Mediated Antitumor Effects by Ketoconazole1

P. Furmanski, Candace S. Johnson, J. Glickson, 2006 .

Effect of 25‐hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients

M. Fakih, D. Trump, Candace S. Johnson, 2011, The Prostate.

Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo

S. Srivastava, Shivendra V. Singh, D. Kokkinakis, 2003 .

Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model.

D. Trump, Candace S. Johnson, R. Rueger, 2002, The Journal of urology.

Vitamin D compounds: clinical development as cancer therapy and prevention agents.

M. Fakih, Wei-dong Yu, D. Trump, 2006, Anticancer research.

Characterization of Vitamin D insensitive prostate cancer cells

M. T. Moser, B. Foster, D. Trump, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Pharmacokinetics of 1α,25-Dihydroxyvitamin D3 in Normal Mice after Systemic Exposure to Effective and Safe Antitumor Doses

D. Trump, Candace S. Johnson, Yibing Peng, 2004, Oncology.

A Limited Sampling Method for the Estimation of Serum Calcitriol Area under the Curve in Cancer Patients

D. Trump, Candace S. Johnson, John W. Wilson, 2003, Journal of clinical pharmacology.

Patients A Limited Sampling Method for the Estimation of Serum Calcitriol Area under the Curve in Cancer

D. Trump, Candace S. Johnson, John W. Wilson, 2003 .

Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia

Q. Hu, Song Liu, G. Wilding, 2014, Cancer.

Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments

Wei-dong Yu, D. Trump, Candace S. Johnson, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.

Wei-dong Yu, D. Trump, Candace S. Johnson, 2006, Cancer research.

Altered VDR-mediated transcriptional activity in prostate cancer stroma

D. Trump, Candace S. Johnson, R. Paredes, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial

M. Mintun, J. Kirkwood, M. Egorin, 2002, Cancer Chemotherapy and Pharmacology.

In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications

P. Furmanski, Candace S. Johnson, Ming-Jei Chang, 1988 .

In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors

Wei-dong Yu, D. Trump, Candace S. Johnson, 2008, Cancer Chemotherapy and Pharmacology.

Pretreatment Serum Concentrations of 25-Hydroxyvitamin D and Breast Cancer Prognostic Characteristics: A Case-Control and a Case-Series Study

S. Edge, S. Yao, M. Nesline, 2011, PloS one.

Potentiation of Interleukin 1α Mediated Antitumor Effects by Ketoconazole

P. Furmanski, Candace S. Johnson, J. Glickson, 1990 .

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Bryan M. Gillard, B. Foster, M. Seshadri, 2009, Cancer research.

1,25D3 Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models

Wei-dong Yu, D. Trump, Candace S. Johnson, 2010, Cancer.

C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells

M. Lotze, P. Hershberger, Candace S. Johnson, 2003, The Prostate.

24-Hydroxylase in cancer: Impact on vitamin D-based anticancer therapeutics

P. Hershberger, D. Trump, Candace S. Johnson, 2013, The Journal of Steroid Biochemistry and Molecular Biology.

Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate

C. Morrison, W. Bshara, A. Omilian, 2011, Epigenetics.

1α,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model

P. Hershberger, Wei-dong Yu, D. Trump, 2008, Molecular Cancer Therapeutics.

Antitumor Effects of Two Less-Calcemic Vitamin D Analogs (Paricalcitol and QW-1624F2-2) in Squamous Cell Carcinoma Cells

B. Foster, D. Trump, Candace S. Johnson, 2007, Oncology.

Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib

C. Morrison, Q. Hu, Jianmin Wang, 2015, Cold Spring Harbor molecular case studies.

The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial

Sin-Ho Jung, J. Garber, I. Bedrosian, 2021, Cancer Prevention Research.

IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data

Dan Wang, Li Yan, Qiang Hu, 2012, Bioinform..

Expression and mutational analysis of MET in human solid cancers

J. Christensen, R. Salgia, E. Vokes, 2008, Genes, chromosomes & cancer.

Vitamin D and Cancer

D. Trump, Candace S. Johnson, 2011 .

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance

A. Hutson, M. Seshadri, C. Lovly, 2020, Cancers.

SCNVSim: somatic copy number variation and structure variation simulator

Qiang Hu, Song Liu, Lei Wei, 2015, BMC Bioinformatics.

Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model

P. Hershberger, D. Trump, Candace S. Johnson, 2015, Cancer Prevention Research.

Vitamin D Signaling Modulators in Cancer Therapy.

D. Trump, Candace S. Johnson, W. Luo, 2016, Vitamins and hormones.

Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.

C. Morrison, D. Trump, Candace S. Johnson, 2010, Cancer research.

Epigenetic Silencing of CYP24 in Tumor-derived Endothelial Cells Contributes to Selective Growth Inhibition by Calcitriol*

N. Nowak, J. Conroy, D. Trump, 2007, Journal of Biological Chemistry.

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage

Jianmin Zhang, Candace S. Johnson, S. Ramakrishnan, 2015, Oncogene.

Vitamin D and Angiogenesis

D. Trump, Candace S. Johnson, Yingyu Ma, 2011 .

Genetic variations in vitamin D‐related pathways and breast cancer risk in African American women in the AMBER consortium

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, K. Lunetta, 2016, International journal of cancer.

EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.

Candace S. Johnson, R. Kandpal, B. Segovia, 2016, Cancer genomics & proteomics.

Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.

Wei-dong Yu, D. Trump, Candace S. Johnson, 2013, Cancer research.

Inhibition of Protein Kinase CK 2 Reduces Cyp 24 a 1 Expression and Enhances 1 , 25-Dihydroxyvitamin D 3 Antitumor Activity in Human Prostate Cancer Cells

Wei-dong Yu, D. Trump, Candace S. Johnson, 2013 .

Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer

Bryan M. Gillard, E. Karasik, M. T. Moser, 2014, PloS one.

The role of vitamin D in cancer prevention and treatment.

D. Trump, Candace S. Johnson, D. Feldman, 2012, Rheumatic diseases clinics of North America.

CYP24A1 inhibition enhances the antitumor activity of calcitriol.

Wei-dong Yu, D. Trump, Candace S. Johnson, 2010, Endocrinology.

Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy

D. Trump, Candace S. Johnson, K. Deeb, 2010, Cancer journal.

The role of vitamin D in cancer prevention and treatment.

D. Trump, Candace S. Johnson, D. Feldman, 2012, Rheumatic diseases clinics of North America.

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.

A. D'Amico, P. Kantoff, D. Lubeck, 2002, Urology.

Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration‐resistant prostate cancer

D. Trump, Candace S. Johnson, M. Wong, 2010, Cancer.

Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate

David C. Smith, R. Day, M. Egorin, 2002, Cancer Chemotherapy and Pharmacology.

Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study

S. Yao, C. Ambrosone, S. McCann, 2012, Breast Cancer Research.

Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk

C. Morrison, K. Guru, P. Hershberger, 2019, Cancer medicine.

Dexamethasone Enhances 1α,25-Dihydroxyvitamin D3 Effects by Increasing Vitamin D Receptor Transcription*

D. Trump, Candace S. Johnson, J. Pike, 2011, The Journal of Biological Chemistry.

Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue

C. Morrison, Q. Hu, Song Liu, 2013, Oncotarget.

Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing

C. Morrison, Q. Hu, Jianmin Wang, 2016, BMC Medical Genomics.

OSAT: a tool for sample-to-batch allocations in genomics experiments

Q. Hu, Jianmin Wang, Song Liu, 2012, BMC Genomics.

Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

Candace S. Johnson, R. Buttyan, V. Montecinos, 2013, American journal of physiology. Endocrinology and metabolism.

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer

C. Morrison, Q. Hu, Jianmin Wang, 2017, Cell Death & Disease.

Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer

Pengyuan Liu, Song Liu, Ming You, 2014, Proceedings of the National Academy of Sciences.

OSAT: a tool for sample-to-batch allocations in genomics experiments

Q. Hu, Jianmin Wang, Song Liu, 2012, BMC Genomics.

Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue

R. Salgia, R. Cheney, M. Tretiakova, 2008, Cancer Epidemiology Biomarkers & Prevention.

P. Hershberger, D. Trump, Candace S. Johnson, 2004, Cancer and Metastasis Reviews.

Mechanistic Insights of Vitamin D Anticancer Effects.

D. Trump, Candace S. Johnson, Yingyu Ma, 2016, Vitamins and hormones.

Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP

L. Arab, E. Fontham, J. Mohler, 2015, PloS one.

A phase 1, open‐label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies

Candace S. Johnson, R. Iyer, M. Javle, 2018, Cancer.

Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).

L. Arab, E. Fontham, J. Mohler, 2018, The American journal of clinical nutrition.

Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells.

D. Trump, Candace S. Johnson, R. Modzelewski, 2002, Endocrinology.

Vitamin D and cancer: clinical aspects.

D. Trump, Candace S. Johnson, A. Woloszynska-Read, 2011, Best practice & research. Clinical endocrinology & metabolism.

Calcitriol (1,25-Dihydroxycholecalciferol) Selectively Inhibits Proliferation of Freshly Isolated Tumor-Derived Endothelial Cells and Induces Apoptosis

Wei-dong Yu, D. Trump, Candace S. Johnson, 2006, Oncology.

Vitamin D receptor: a potential target for intervention.

P. Hershberger, T. Mcguire, D. Trump, 2002, Urology.

Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs

D. Trump, Candace S. Johnson, K. Rassnick, 2010, Cancer Chemotherapy and Pharmacology.

The antitumor efficacy of calcitriol: preclinical studies.

P. Hershberger, D. Trump, Candace S. Johnson, 2006, Anticancer research.

Antiproliferative effects in vitro and in vivo of 1,25-dihydroxyvitamin D3 and a vitamin D3 analog in a squamous cell carcinoma model system

David C. Smith, D. Trump, Candace S. Johnson, 1995 .

Postoperative Restrictive Opioid Protocols and Durable Changes in Opioid Prescribing and Chronic Opioid Use.

A. Fabiano, K. Odunsi, W. Hicks, 2023, JAMA oncology.

TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)

C. Morrison, W. Bshara, Dan Wang, 2019, Cell cycle.

MP38-05 TUMOR DISSEMINATION DURING ROBOT-ASSISTED RADICAL CYSTECTOMY: DOES THE EMPEROR HAVE NO CLOTHES?

K. Guru, S. Glenn, N. Hinata, 2016 .

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer

C. Morrison, Q. Hu, Jianmin Wang, 2017, Cell Death & Disease.

Vitamin D and miRNAs in cancer.

D. Trump, Candace S. Johnson, Yingyu Ma, 2014, Current Gene Therapy.

MAC: identifying and correcting annotation for multi-nucleotide variations

C. Morrison, Q. Hu, Jianmin Wang, 2015, BMC Genomics.

1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells

Q. Hu, Song Liu, S. Glenn, 2015, The Journal of Steroid Biochemistry and Molecular Biology.

1 a , 25 ( OH ) 2 D 3 differentially regulates miRNA expression in human bladder cancer cells

Q. Hu, Song Liu, S. Glenn, 2015 .

DOES AGGRESSIVENESS OF TUMOR STAGE CORRELATE WITH INTRA‐OPERATIVE PELVIC WASHINGS & PNEUMO‐PERITONEUM DURING ROBOT‐ASSISTED RADICAL CYSTECTOMY?: MP88‐13

K. Guru, S. Glenn, Candace S. Johnson, 2017 .

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.

R. Day, R. Dhir, D. Trump, 1997, Urology.

The role of vitamin D in cancer prevention and treatment.

D. Trump, Candace S. Johnson, D. Feldman, 2010, Endocrinology and metabolism clinics of North America.

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

D. Smith, D. Trump, Candace S. Johnson, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.

D. Smith, Wei-dong Yu, D. Trump, 1998, Journal of the National Cancer Institute.

Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.

Wei-dong Yu, D. Trump, Candace S. Johnson, 1997, Cancer research.

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage

Jianmin Zhang, Candace S. Johnson, S. Ramakrishnan, 2015, Oncogene.

25(OH) Vitamin D3 Affects Acute Myeloid Leukemia Cell Proliferation

C. Frangou, N. Nowak, D. Trump, 2013 .

Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.

P. Hershberger, T. Mcguire, Wei-dong Yu, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

SCNVSim: somatic copy number variation and structure variation simulator

C. Morrison, Q. Hu, Jianmin Wang, 2015, BMC Bioinformatics.

1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.

P. Hershberger, D. Trump, Candace S. Johnson, 1999, Cancer research.

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

P. Hershberger, Wei-dong Yu, D. Trump, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A new immunocompetent murine model for oral cancer.

Candace S. Johnson, M. Schwartz, B. O'Malley, 1997, Archives of otolaryngology--head & neck surgery.

Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.

C. Morrison, D. Trump, Candace S. Johnson, 2010, Cancer Research.

Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1.

T. Mcguire, D. Trump, Candace S. Johnson, 2001, The Journal of biological chemistry.

Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.

D. Trump, Candace S. Johnson, K. Lew, 2003, Carcinogenesis.

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Bryan M. Gillard, B. Foster, M. Seshadri, 2009, Cancer research.

Vitamin D Signaling Modulators in Cancer Therapy.

D. Trump, Candace S. Johnson, W. Luo, 2016, Vitamins and hormones.

Inecalcitol, an analog of 1,25D₃, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system

Wei-dong Yu, D. Trump, Candace S. Johnson, 2013, Cell cycle.

Vitamin D and Acute Myeloid Leukemia

D. Trump, Candace S. Johnson, M. Wetzler, 2011 .

Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.

B. Foster, Fengzhi Li, C. Porter, 2010, The American journal of pathology.